Free Access
| Issue |
J. Soc. Biol.
Volume 203, Number 2, 2009
Angiogenèse : de la biologie à la thérapeutique
|
|
|---|---|---|
| Page(s) | 193 - 195 | |
| DOI | https://doi.org/10.1051/jbio/2009023 | |
| Published online | 16 juin 2009 | |
- Azoulay D., Adam R., Lemoine A., Bismuth H., Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg, 2000, 232, 777–785. [CrossRef] [PubMed] [Google Scholar]
- Beck D.E., Cohen Z., Fleshman J.W., Kaufman H.S., van Goor H., Wolff B.G., Adhesion Study Group Steering Comittee. A prospective, randomized, multicenter, controlled study of the safety of Seprafilm adhesion barrier in abdominopelvic surgery of the intestine. Dis Colon rectum, 2003, 46, 1310–1399. [Google Scholar]
- Bergers G., Benjamin L.E., Tumorigenesis and the angiogenic swith. Nat Rev Cancer, 2003, 3, 401–410. [Google Scholar]
- D'Angelica M., Kornprat P., Gonen M., Chung K.Y., Jarnagin W.R., DeMatteo R.P., Fong Y., Kemeny N., Blumgart L.H., Saltz L.B., Lack of evidence for increased operative morbidity after hepatectomy with perioperative use of bevacizumab: a matched case-control study. Ann Surg Oncol, 2007, 14, 759–765. [CrossRef] [PubMed] [Google Scholar]
- Elias D., De Baere T., Roche A., Ducreux M., Leclere J., Lasser P., During liver regeneration following right portal embolization the growth rate of liver metastases is more rapid than that of the liver parenchyma. Brit J Surg, 1999, 86, 784–788. [CrossRef] [Google Scholar]
- Elias D., Santoro R., Ouellet JF., Osmak L., de Baere T., Roche A., Simultaneous percutaneous right portal vein embolization and left liver tumor radiofrequency ablation prior to a major right hepatic resection for bilateral colorectal metastases. Hepatogastroenterology, 2004, 51, 1788–1791. [PubMed] [Google Scholar]
- Eveno C., Gaujoux S., Tobelem G., Pocard M., Did animal offer relevant model for Bevacizumab testing ? Br J Cancer, 2008, 99, 1555. [Google Scholar]
- Lefevre J.H., Rondelli F., Mourra N., Bennis M., Tiret E., Parc R., Parc Y., Lumboaortic and iliac lymphadenectomy for lymph node recurrence of colorectal cancer: prognostic value of the MSI phenotype. Ann Surg Oncol, 2008, 15, 2433–2438. [CrossRef] [PubMed] [Google Scholar]
- Ma J., Waxman D.J., Combination of antiangiogenesis with chemotherapy for more effective cancer treatment. Mol Cancer Ther, 2008, 7, 3670–3684. [Google Scholar]
- Morris-Stiff G., Tan Y.M., Vauthey J.N., Hepatic complications following preoperative chemotherapy with oxaliplatin or irinotecan for hepatic colorectal metastases. Eur J Surg Oncol, 2008, 34, 609–614. [CrossRef] [PubMed] [Google Scholar]
- Nicoli S., Ribatti D., Cotelli F., Presta M., Mammalian tumor xenografts induce neovascularization in zebrafish embryos. Cancer Res, 2007, 67, 2927–2931. [CrossRef] [MathSciNet] [PubMed] [Google Scholar]
- Pocard M., Debruyne P., Mareel M., Dutrillaux B., Poupon M.-F., Single alteration of p53 or E-cadherin genes can alter the surgical benefit in an experimental model of colon cancer. Dis Colon Rectum, 2001a, 44, 1106–1112. [CrossRef] [PubMed] [Google Scholar]
- Pocard M., Vincent-Salomon A., Girodet J., Salmon R.-J., Effects of preoperative chemotherapy on liver function test after hepatectomy. Hepatogastroenterology, 2001b, 48, 1406–1408. [PubMed] [Google Scholar]
- Ribero D., Wang H., Donadon M., Zorzi D., Thomas M.B., Eng C., Chang D.Z., Curley S.A., Abdalla E.K., Ellis L.M., Vauthey J.N., Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases. Cancer, 2007, 110, 2761–2767. [CrossRef] [PubMed] [Google Scholar]
- Willett C.G., Boucher Y., di Tomaso E., Duda D.G., Munn L.L., Tong R.T., et al., Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med, 2004, 10, 145–147. [CrossRef] [PubMed] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.